EUVIMEDEUVIMED entdecken
Open Access

Lnc-ZEB2-19 Inhibits the Progression and Lenvatinib Resistance of Hepatocellular Carcinoma by Attenuating the NF-κB Signaling Pathway through the TRA2A/RSPH14 Axis

Mingbo Cao, Yupeng Ren, Yuxuan Li, Junfeng Deng, Xiaorui Su, Yongchang Tang, Feng Yuan, Haixia Deng, Gaoyuan Yang, Zhiwei He, Bo Liu, Zhicheng Yao und 1 weitere

International Journal of Biological Sciences · 2023

DOI: 10.7150/ijbs.85270 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Biological Sciences, 2023. Verfasst von Mingbo Cao und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary Surgery, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510630, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, RNA, Long Noncoding. Die Arbeit wurde bisher 14-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsRNA, Long NoncodingHumansCell Line, TumorGene Expression Regulation, NeoplasticNF-kappa BSignal TransductionZinc Finger E-box Binding Homeobox 2Drug Resistance, NeoplasmPhenylurea CompoundsQuinolinesRNA-Binding Proteins

Stichwörter der Autor:innen

Hepatocellular CarcinomaLenvatinib resistanceLnc-ZEB2-19TRA2AmRNA stability

Substanzen

NF-kappa BZinc Finger E-box Binding Homeobox 2RNA, Long NoncodinglenvatinibPhenylurea CompoundsQuinolinesZEB2 protein, humanTRA2A protein, humanRNA-Binding Proteins

Autor:innen und Institutionen

  • Department of Hepatobiliary Surgery, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510630, China.
  • Department of Hepatobiliary & Pancreatic Surgery, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510630, China.
  • Department of General Surgery, Qilu Hospital, Shandong University, Jinan, China.
  • Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510120, China.

Zitieren

APA

Cao, M., Ren, Y., Li, Y., Deng, J., Su, X., Tang, Y., Yuan, F., Deng, H., Yang, G., He, Z., Liu, B., Yao, Z., & Deng, M. (2023). Lnc-ZEB2-19 Inhibits the Progression and Lenvatinib Resistance of Hepatocellular Carcinoma by Attenuating the NF-κB Signaling Pathway through the TRA2A/RSPH14 Axis. International Journal of Biological Sciences. https://doi.org/10.7150/ijbs.85270

Vancouver

Cao M, Ren Y, Li Y, Deng J, Su X, Tang Y, et al. Lnc-ZEB2-19 Inhibits the Progression and Lenvatinib Resistance of Hepatocellular Carcinoma by Attenuating the NF-κB Signaling Pathway through the TRA2A/RSPH14 Axis. International Journal of Biological Sciences. 2023. doi:10.7150/ijbs.85270

BibTeX
@article{Cao2023,
  author = {Cao, Mingbo and Ren, Yupeng and Li, Yuxuan and Deng, Junfeng and Su, Xiaorui and Tang, Yongchang and Yuan, Feng and Deng, Haixia and Yang, Gaoyuan and He, Zhiwei and Liu, Bo and Yao, Zhicheng and Deng, Meihai},
  title = {Lnc-ZEB2-19 Inhibits the Progression and Lenvatinib Resistance of Hepatocellular Carcinoma by Attenuating the NF-κB Signaling Pathway through the TRA2A/RSPH14 Axis},
  journal = {International Journal of Biological Sciences},
  year = {2023},
  doi = {10.7150/ijbs.85270}
}
Kostenlos starten →